RDY

Dr Reddy's Laboratories Limited
D

RDY

15.310
USD
0.08
(0.49%)
مغلق
حجم التداول
39,179
الربح لكل سهم
70
العائد الربحي
0.63
P/E
20
حجم السوق
12,739,739,287
التوصيات
Moustafa El khaldy
Moustafa El khaldy
منذ 11 شهر
sell
RDY
RDY@76.07
2024-07-05 05:47
RDY@76.07 Chart
الربح
9.00
المزيد
أصول ذات صلة
AZN
AZN
0.690
(0.99%)
70.640 USD
GSK
GSK
0.215
(0.57%)
38.260 USD
LLY
LLY
7.32
(0.96%)
770.47 USD
MRK
MRK
1.090
(1.38%)
80.200 USD
NVS
NVS
1.840
(1.59%)
117.580 USD
PFE
PFE
0.060
(0.25%)
24.030 USD
SNY
SNY
0.325
(0.68%)
48.215 USD
TEVA
TEVA
-0.005
(-0.03%)
16.965 USD
المزيد
الأخبار المقالات

العنوان: Dr. Reddy's Laboratories Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.